Biotechnology Massachusetts, USA-based Entact Bio, co-founded in 2019 by an international group of researchers to develop precision medicines that enhance the function of key proteins, announced it has raised $81 million in Series A financing to advance its proprietary Encompass platform for developing enhancement-targeting chimeric (ENTAC) molecules. 7 December 2022